Reviews
Summary
Positives
- Immunosuppressed patients on Evusheld commonly see fewer breakthrough COVID-19 infections, hospitalizations, and deaths overall MDPI Vaccines.
- Patients given a single dose of Evusheld commonly avoid symptomatic COVID-19 for around six months AstraZeneca.
- Real-world data from a large academic center confirmed reduced infection rates in transplant, hematologic malignancy, and immunosuppressed rheumatology patients PMC.
Negatives
- An autoimmune patient got COVID three times in one year despite receiving Evusheld and full boosting Reddit.
Hurdles & Side Effects
- Evusheld has been discontinued as ineffective against newer variants; successor products have limited availability Reddit.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care
Get Tixagevimab/Cilgavimab (Evusheld)
Providers
0 matches
No linked providers yet.
Pharmacies
0 matches
No linked pharmacies yet.